Clinical Trials Browser

Neoplasms × Panobinostat × Genitourinary × Clear all

NCT00667862 2021-06-21

Efficacy and Safety Study of Panobinostat in Participants With Metastatic Hormone Refractory Prostate Cancer

Phase 2 Completed

35 enrolled 8 charts

Adenocarcinoma, Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

NCT00663832 2020-12-19

A Dose Finding Study With I.V. Panobinostat (LBH589), Docetaxel, and Prednisone in Patients With Hormone Refractory Prostate Cancer

Phase 1 Completed

Neoplasms, Prostatic Neoplasms